A laboratory ships documentation with a batch. An independent batch test adds something documentation by definition cannot: an independent verification of this specific batch.
MVMichel van der VeenRegistered Nurse · Science Editor, Peptalis Sources checked via PubMed · 2 referencesReviewed 15 JULY 2026 · 7 MIN READA batch of research material comes with paperwork. In practice two things fill that paperwork: the documentation the laboratory provides, and the verification a buyer adds to it. They resemble each other and are often read as the same, but they do different things. The distinction decides how much certainty actually sits behind a vial.
What lab documentation is
Lab documentation is the analytical data the producing laboratory provides with a batch, bundled in the lab certificate. It typically states the identity by mass spectrometry, the purity by HPLC, the batch number and the test date. It is a real and valuable document: the first layer of information about what was made.
But it is a statement by one party about its own product. That does not make a laboratory untrustworthy; it means the data has not been independently confirmed. And documentation describes the batch as it was at the laboratory on the test date, not the vial as it arrives after transport and storage. Peptide batches also differ from one another: the exact impurity profile and even the counterion content can vary between production rounds, which makes per-batch quantification relevant (Erckes et al., 2025). A certificate for batch A is not a statement about batch B.
What an independent batch verification adds
An independent batch verification is a second, independent check of exactly this batch. Where lab documentation says "this is what we measured", independent verification says "this is what we, after receipt, established ourselves". That difference is the core.
At Peptalis every batch passes through a fixed chain. Peptalis obtains peptides from specialised laboratories and manufacturers and requires extensive analytical lab testing as part of selection; that lab data is the first layer. Then comes an internal assessment following a fixed procedure: checks on identity, purity and stability, visual inspection and vial integrity, and where relevant a reconstitution test. Only when those steps hold does Peptalis issue its own Certificate of Analysis: on its own letterhead, with the lab data and the Peptalis verification layer, signed by the Peptalis Research Team, in Dutch or English according to the order. Where Peptalis sees reason to, a batch can additionally be tested at an independent European laboratory; that report is an internal control instrument, not a public seal of approval. A batch that does not meet the standard is rejected and does not enter the catalogue.
The gain is not that the laboratory is distrusted, but that the certainty does not rest on a single unverified source. Two independent measurements that agree say more than one. This follows the same logic as why analytical methods complement each other: no single number, and no single source, is asked to prove more than it can (Lian et al., 2021).
Traceability: from vial to batch to document
Verification is only useful if it can be traced. Traceability is the chain that connects the vial in hand to the batch, the test date and the associated documents.
That chain runs in four steps. The vial carries a batch number on its label. That number points to a released batch record. The batch record links internally to the lab certificate and to the Peptalis test results. And each of those documents carries a test date, which places the measurements in time. From the number on the vial it is therefore possible to trace back to exactly what was tested and when. At Peptalis every order ships as standard with the own Peptalis CoA (the release report, in Dutch or English), the batch number and the storage conditions, so that this chain can be followed in full; the underlying lab certificate stays an internal source.
When a link is missing, the chain breaks. A vial without a traceable batch number cannot be tied to a certificate; a certificate without a test date loses its place in time. Traceability is precisely the antidote to that break.
What Peptalis does and does not test itself
Transparency belongs to this distinction. Peptalis shows what it verifies itself and names what it does not establish itself. The internal assessment (identity, purity, stability, visual and vial integrity) is what Peptalis adds to the lab data. Additional tests at an independent laboratory happen on indication, as internal quality assurance, and are not presented as a public partner claim or a seal.
What has been verified is shown; what could not be established is named as such. That is the difference between passing documentation along and adding verification, and it is why an independent batch test is something other than a lab certificate, however good that certificate may be.
About the authorMVMichel van der VeenRegistered Nurse · Science Editor, PeptalisRegistered nurse with eleven years in psychiatry and founder of Peptalis. Writes the platform's knowledge layer: compound profiles, evidence reviews and the quality methodology. Works from primary literature (PubChem for chemistry, PubMed for studies) and states where evidence is absent.
Sources checked via PubMed · 2 references
Compound profilesEvidence reviewsQualityIN THIS ARTICLE- What lab documentation is
- What an independent batch verification adds
- Traceability: from vial to batch to document
- What Peptalis does and does not test itself
- In DepthCertificate of Analysis: what it does and does not say
- In DepthHPLC purity vs. peptide content
Compounds in this article
- Epitalon · In stock · Batch PEP-EPI-2026-01 · HPLC 99.11% · released 2 Jun 2026 · Research profile · View in catalogue
- Ipamorelin · Not in catalogue · Research profile
For laboratory research use only. Not for human use.
SCIENTIFIC REFERENCES
These references are provided for informational and research purposes only. They do not constitute medical advice.
- 01Method / AnalyticalTowards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides.Erckes V, et al. Pharmaceuticals (Basel). 2025;18(8):1163.Consensus-oriented analysis showing that TFA counterion content (and therefore weighed mass) can vary meaningfully between production rounds of the same peptide, which is why per-batch quantification matters.View on PubMed →
- 02Review / MethodCharacterization of Synthetic Peptide Therapeutics Using LC-MS.Lian Z, Wang N, Tian Y, Huang L. J Am Soc Mass Spectrom. 2021;32(8):1852–1860.Methodological review of LC-MS characterisation for synthetic peptide therapeutics, illustrating why complementary, independent analytical readouts are more informative than a single number from one source.View on PubMed →